A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis

被引：0

作者：

Christina van Stein

Sabrina Klank

Marianne Grüneberg

Chris Ottolenghi

Jürgen Grebe

Janine Reunert

Erik Harms

Thorsten Marquardt

机构：

[1] University of Muenster,Department of General Pediatrics, Metabolic Diseases

[2] Université Paris Descartes,UMR 1163

[3] Sorbonne Paris Cité,Biochimie Métabolique et Protéomique

[4] Institut IMAGINE,undefined

[5] Hôpital Necker – Enfants Malades,undefined

来源：

Orphanet Journal of Rare Diseases | / 16卷

关键词：

Nephropathic cystinosis; Immediate-release cysteamine; Delayed-release cysteamine;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] IMPACT OF IMPROVED TREATMENT COMPLIANCE WITH DELAYED-RELEASE CYSTEAMINE BITARTRATE CAPSULES ON THE COSTS OF END STAGE RENAL DISEASE FOR PATIENTS WITH NEPHROPATHIC CYSTINOSIS IN THE UNITED KINGDOM
Lashilola, Seun
Xu, Weiwei
Brandi, Giacomo
Azimpour, Khashayar
Carlot, Sara
PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2909 - 2910
[22] Improvement of Tubular Function in Infantile Nephropathic Cystinosis after Delayed Onset of Cysteamine Treatment
Wade, A. W.
Midgley, J. P.
PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1921 - 1922
[23] An extended-release form of cysteamine bitartrate for cystinosis
Susan J. Allison
Nature Reviews Nephrology, 2012, 8 (7) : 374 - 374
[24] Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up
Dohil, Ranjan
Cabrera, Betty L.
PEDIATRIC NEPHROLOGY, 2013, 28 (03) : 507 - 510
[25] Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up
Ranjan Dohil
Betty L. Cabrera
Pediatric Nephrology, 2013, 28 : 507 - 510
[26] A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: Effectiveness on white blood cell cystine levels and comparison of safety (vol 7, pg 1112, 2012)
Langman, C. B.
Greenbaum, L. A.
Sarwal, M.
Grimm, P.
Niaudet, P.
Deschenes, G.
Cornelissen, E.
Morin, D.
Cochat, P.
Matossian, D.
Gaillard, S.
Bagger, M. J.
Rioux, P.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (03): : 468 - 468
[27] CYSTEAMINE IN RENAL TRANSPLANTATION: A REPORT OF TWO PATIENTS WITH NEPHROPATHIC CYSTINOSIS AND THE SUCCESSFUL RE- INITIATION OF CYSTEAMINE THERAPY IN THE IMMEDIATE POST-TRANSPLANT PERIOD
Berryhill, A.
Bhamre, S.
Chaudhuri, A.
Concepcion, W.
Grimm, P.
PEDIATRIC TRANSPLANTATION, 2015, 19 : 108 - 108
[28] CYSTEAMINE EYEDROPS DISSOLVE CORNEAL CRYSTALS IN YOUNG-PATIENTS WITH NEPHROPATHIC CYSTINOSIS
GAHL, W
FUJIKAWA, I
KUWABARA, T
JAIN, S
KAISERKUPFER, MI
PEDIATRIC RESEARCH, 1987, 21 (04) : A289 - A289
[29] A COMPARISON OF THE EFFECTIVENESS OF CYSTEAMINE AND PHOSPHOCYSTEAMINE IN ELEVATING PLASMA CYSTEAMINE CONCENTRATION AND DECREASING LEUKOCYTE FREE CYSTINE IN NEPHROPATHIC CYSTINOSIS
SMOLIN, LA
CLARK, KF
THOENE, JG
GAHL, WA
SCHNEIDER, JA
PEDIATRIC RESEARCH, 1988, 23 (06) : 616 - 620
[30] An Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Cysteamine Bitartrate Delayed-release Capsules (RP103), Compared to Cysteamine Bitartrate Capsules, (Cystagon®) in Patients with Nephropathic Cystinosis
Rioux, P.
Barshop, B.
PEDIATRIC NEPHROLOGY, 2010, 25 (10) : 2197 - 2197

← 1 2 3 4 5 →